Reactions 1704, p45 - 2 Jun 2018 Frailty: case report A 92-year-old man developed frailty during treatment with apixaban for non-occlusive deep vein thrombosis of right femoral, popliteal and proximal posterior tibial veins. The man, who had chronic lymphocytic leukaemia, immune thrombocytopenic purpura, hypertension, hyperlipidaemia, was started on apixaban 2.5mg twice daily [route not stated] for non-occlusive deep vein thrombosis of right femoral, popliteal and proximal posterior tibial veins. Initially, the medication was tolerated. However, two months later, he started having generalised weakness, decreased appetite and increased tendency to fall. He had few falls at home, weight loss of around ten pounds, fatigue and reduced activity level. Based on these symptoms fraility was confirmed. His haemoglobin, metabolic panel and thyroid stimulating hormone were normal. After ruling out infectious and metabolic causes, his frailty was attributed to apixaban. After completing three months treatment of apixaban, it was stopped after haematology consultation. The man began feeling well with improved appetite, fatigue and activity level. At follow-up, he was back to his baseline performance status. Author comment: "We report a case of frailty in elderly patient due to apixaban use." Priyambada P, et al. Frailty associated with apixaban: A case report and review of literature. Journal of the American Geriatrics Society 66 (Suppl. 2): S184, Apr 2018. Available from: URL: http://doi.org/10.1111/jgs.15376 [abstract] - USA 803323549 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera